Log in

NYSE:THCTenet Healthcare Stock Price, Forecast & News

$18.21
-0.26 (-1.41 %)
(As of 07/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$18.11
Now: $18.21
$19.33
50-Day Range
$17.16
MA: $20.96
$25.80
52-Week Range
$10.00
Now: $18.21
$39.37
Volume1.31 million shs
Average Volume2.46 million shs
Market Capitalization$1.91 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.33
Tenet Healthcare Corporation operates as a diversified healthcare services company. The company operates in three segments: Hospital Operations and Other, Ambulatory Care, and Conifer. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and coronary care units; physical therapy, orthopedic, oncology, and outpatient services; cardiothoracic surgery, neonatal intensive care, and neurosurgery services; quaternary care in heart, liver, kidney, and bone marrow transplants areas; tertiary and quaternary pediatric, and burn services; and limb-salvaging vascular procedures, acute level 1 trauma services, intravascular stroke care, minimally invasive cardiac valve replacement, imaging technology, and telemedicine access for various medical specialties. In addition, it operates ambulatory surgery and urgent care centers, imaging centers, and surgical hospitals; and offers healthcare business process services in the areas of hospital and physician revenue cycle management, as well as value-based care solutions to healthcare systems, individual hospitals, physician practices, self-insured organizations, health plans, and other entities. As of December 31, 2018, the company operated 68 hospitals, 23 surgical hospitals, and approximately 475 outpatient centers, as well as 255 ambulatory surgery, 36 urgent care, and 23 imaging centers in the United States. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.
Read More
Tenet Healthcare logo

Beat the Market (BTM) Rank

Analyst Opinion: 4.2Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.86 out of 5 stars


Industry, Sector and Symbol

Industry General medical & surgical hospitals
Sub-IndustryHealth Care Facilities
SectorMedical
CUSIP88033G40
Phone469-893-2200

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$18.48 billion
Cash Flow$11.24 per share
Book Value$4.65 per share

Profitability

Net Income$-232,000,000.00

Miscellaneous

Employees113,600
Market Cap$1.91 billion
Next Earnings Date8/3/2020 (Estimated)
OptionableOptionable

Receive THC News and Ratings via Email

Sign-up to receive the latest news and ratings for THC and its competitors with MarketBeat's FREE daily newsletter.

Tenet Healthcare (NYSE:THC) Frequently Asked Questions

How has Tenet Healthcare's stock been impacted by COVID-19 (Coronavirus)?

Tenet Healthcare's stock was trading at $19.99 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, THC stock has decreased by 8.9% and is now trading at $18.21. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Tenet Healthcare?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tenet Healthcare in the last year. There are currently 6 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Tenet Healthcare.

When is Tenet Healthcare's next earnings date?

Tenet Healthcare is scheduled to release its next quarterly earnings announcement on Monday, August 3rd 2020. View our earnings forecast for Tenet Healthcare.

How were Tenet Healthcare's earnings last quarter?

Tenet Healthcare Corp (NYSE:THC) issued its earnings results on Monday, May, 4th. The company reported $1.28 earnings per share for the quarter, topping analysts' consensus estimates of $0.32 by $0.96. The firm earned $4.52 billion during the quarter, compared to analysts' expectations of $4.63 billion. Tenet Healthcare had a negative net margin of 0.65% and a positive return on equity of 65.69%. The firm's revenue for the quarter was down .6% on a year-over-year basis. During the same period in the prior year, the firm earned $0.54 earnings per share. View Tenet Healthcare's earnings history.

What price target have analysts set for THC?

11 brokerages have issued 12 month target prices for Tenet Healthcare's shares. Their forecasts range from $22.00 to $33.00. On average, they expect Tenet Healthcare's share price to reach $28.18 in the next year. This suggests a possible upside of 54.8% from the stock's current price. View analysts' price targets for Tenet Healthcare.

Has Tenet Healthcare been receiving favorable news coverage?

Media stories about THC stock have been trending negative on Saturday, InfoTrie reports. The research firm identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Tenet Healthcare earned a media sentiment score of -2.8 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 7.0 out of 10, meaning that recent news coverage is likely to have an impact on the stock's share price in the near future. View the latest news about Tenet Healthcare.

Are investors shorting Tenet Healthcare?

Tenet Healthcare saw a increase in short interest in the month of June. As of June 15th, there was short interest totaling 9,570,000 shares, an increase of 5.4% from the May 31st total of 9,080,000 shares. Based on an average trading volume of 2,890,000 shares, the days-to-cover ratio is presently 3.3 days. Approximately 9.3% of the company's stock are short sold. View Tenet Healthcare's Current Options Chain.

Who are some of Tenet Healthcare's key competitors?

What other stocks do shareholders of Tenet Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tenet Healthcare investors own include Micron Technology (MU), Alibaba Group (BABA), Advanced Micro Devices (AMD), Delta Air Lines (DAL), Walt Disney (DIS), Netflix (NFLX), Bank of America (BAC), General Electric (GE), Starbucks (SBUX) and NVIDIA (NVDA).

Who are Tenet Healthcare's key executives?

Tenet Healthcare's management team includes the following people:
  • Mr. Ronald A. Rittenmeyer, Exec. Chairman & CEO (Age 72)
  • Mr. Daniel J. Cancelmi, Chief Financial Officer (Age 56)
  • Ms. Audrey T. Andrews, Sr. VP & Gen. Counsel (Age 52)
  • Mr. Keith B. Pitts, Vice Chairman (Age 61)
  • Mr. Saumya Sutaria M.D., Chief Operating Officer (Age 46)

What is Tenet Healthcare's stock symbol?

Tenet Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "THC."

How do I buy shares of Tenet Healthcare?

Shares of THC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Tenet Healthcare's stock price today?

One share of THC stock can currently be purchased for approximately $18.21.

How big of a company is Tenet Healthcare?

Tenet Healthcare has a market capitalization of $1.91 billion and generates $18.48 billion in revenue each year. The company earns $-232,000,000.00 in net income (profit) each year or $2.68 on an earnings per share basis. Tenet Healthcare employs 113,600 workers across the globe.

What is Tenet Healthcare's official website?

The official website for Tenet Healthcare is www.tenethealth.com.

How can I contact Tenet Healthcare?

Tenet Healthcare's mailing address is 14201 Dallas Parkway, DALLAS TX, 75254. The company can be reached via phone at 469-893-2200 or via email at [email protected]

This page was last updated on 7/4/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.